MedPath

Effect of chemotherapy and chemoradiotherapyon stomach cancer

Not Applicable
Recruiting
Conditions
Gastric and cardiac cancer.
Malignant neoplasm of stomach
Registration Number
IRCT2017100236514N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

stomach or cardiac cancer; resectable locally advanced Timor (T3 or T4 with pricardial or pleural or diaphragmatic involvement, or N1 and more); no metastasis; ages 18_75; normal liver and renal function test; performance statues (ps) 0_1.
Exclusion criteria: T1_2 N0, unresectable tumors(T4b); peritoneal or visceral metastasis; non regional lymph node extension such as paraaortic or mesantric; age <18 or >75; impaired liver or renal function test and PS 2 and more.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathologic complete response. Timepoint: 6_8 weeks after completion of them I radiotherapy, in surgical specimen. Method of measurement: microscopic assessment of surgical specimen by pathologist.
Secondary Outcome Measures
NameTimeMethod
Surgical margin. Timepoint: after intervention, in surgical specimen. Method of measurement: microscopic assessment of surgical specimen by pathologist.
© Copyright 2025. All Rights Reserved by MedPath